Tao W, Xu X, Wang X, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J]. J Ethnopharmacol, 2013, 145(1):1.
[5]
O\'boyle N M, Banck M, James C A, et al. Open babel:an open chemical toolbox[J]. J Cheminform, 2011, 3:33.
[6]
Jabbour H N, Sales K J. Prostaglandin receptor signalling and function in human endometrial pathology[J]. Trends Endocrinol Metab, 2004, 15(8):398.
[7]
Edwards A K, Nakamura D S, Virani S, et al. Animal models for anti-angiogenic therapy in endometriosis[J]. J Reprod Immunol, 2013, 97(1):85.
[8]
Islam M S, Akhtar M M, Ciavattini A, et al. Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues:promising options for prevention and treatment of uterine fibroids?[J]. Mol Nutr Food Res, 2014, 58(8):1667.
[9]
Wu M H, Lu C W, Chuang P C, et al. Prostaglandin E2:the master of endometriosis?[J]. Exp Biol Med, 2010, 235(6):668.
[10]
Jabbour H N, Sales K J, Smith O P M, et al. Prostaglandin receptors are mediators of vascular function in endometrial pathologies[J]. Mol Cell Endocrinol, 2006, 252(1/2):191.
[11]
Taylor D K, Leppert P C. Treatment for uterine fibroids:searching for effective drug therapies[J]. Drug Discov Today, 2012, 9(1):e41.
[12]
Maybin J A, Critchley H O D, Jabbour H N. Inflammatory pathways in endometrial disorders[J]. Mol Cell Endocrinol, 2011, 335(1):42.
[13]
Zhao L, Yang H, Xuan Y, et al. Increased expression of fibroblast growth factor receptor 1 in endometriosis and its correlation with endometriosis-related dysmenorrhea and recurrence[J]. Eur J Obstet Gynecol Reprod Biol, 2015,184:117.
[14]
Kelly R W, King A E, Critchley H O. Cytokine control in human endometrium[J]. Reproduction, 2001, 121(1):3.
[15]
Marret H, Fritel X, Ouldamer L, et al. Therapeutic management of uterine fibroid tumors:updated French guidelines[J]. Eur J Obstet Gynecol Reprod Biol, 2012, 165(2):156.
[16]
Jiang X, Kumar K, Hu X, et al. DOVIS 2.0:an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0[J]. Chem Cent J, 2008, 2:18.
Kanehisa M, Goto S, Furumichi M, et al. KEGG for representation and analysis of molecular networks involving diseases and drugs[J]. Nucleic Acids Res, 2010, 38:D355.
[19]
Smoot M E, Ono K, Ruscheinski J, et al. Cytoscape 2.8:new features for data integration and network visualization[J]. Bioinformatics, 2011, 27(3):431.
[20]
Saito R, Smoot M E, O?? K, et al. A travel guide to cytoscape plugins[J]. Nat Methods, 2012, 9(11):1069.
[21]
Barabási A L. Scale-free networks:a decade and beyond[J]. Science, 2009, 325(5939):412.
[22]
Xu X, Luo J W, Gu Y T. Collective dynamics and control of a 3-D small-world network with time delays[J]. Int J Bifurcat Chaos, 2012, 22(11):1250281.
[23]
Zhou W X, Cheng X R, Zhang Y X. Network pharmacology——a new philosophy for understanding of drug action and discovery of new drugs[J]. Chin J Pharmacol Toxicol, 2012, 26(1):4.
Howard F M. Endometriosis and mechanisms of pelvic pain[J]. J Minim Invas Gyn, 2009, 16(5):540.
[28]
Sioutas A, Ehrén I, Lundberg J O, et al. Intrauterine nitric oxide in pelvic inflammatory disease[J]. Fertil Steril, 2008, 89(4):948.
[29]
Sun M F, Huang H C, Lin S C, et al. Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan[J]. Life Sci, 2005, 76(17):2005.
[30]
Wilhelmsson L, Lindblom B, Wikland M, et al. PGI2 may play a role in the pathophysiology of dysmenorrhea[J]. Acta Obstet Gynecol Scand Suppl, 1983, 113:69.
[31]
Koohestani F, Mcwilliams M M, Wertenberger R A, et al. WNT and mTOR pathways in the G-protein coupled receptor 10 (GPR10) transgenic mouse model of uterine fibroids[J]. Ferti Steril, 2014, 102(3Supplement):e3.
[32]
Bakas P, Liapis A, Vlahopoulos S, et al. Estrogen receptor α and β in uterine fibroids:a basis for altered estrogen responsiveness[J]. Fertil Steril, 2008, 90(5):1878.
[33]
Chwalisz K, Perez M C, Demanno D, et al. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis[J]. Endocr Rev, 2005, 26(3):423.
[34]
Kilic I, Oksuz-Kanbur N, Derman O, et al. Role of leukotrienes in the pathogenesis of dysmenorrhea in adolescent girls[J]. Turk J Pediatr, 2008, 50(6):52
